Holen Sie sich die Stockscreener-App
283.36
0.50%
1.42
Handel nachbörslich:
283.36
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$281.94
Offen:
$282.46
24-Stunden-Volumen:
627.52K
Relative Volume:
0.97
Marktkapitalisierung:
$23.24B
Einnahmen:
$14.14B
Nettoeinkommen (Verlust:
$942.70M
KGV:
25.11
EPS:
11.2856
Netto-Cashflow:
$1.38B
1W Leistung:
+2.37%
1M Leistung:
+9.17%
6M Leistung:
+4.61%
1J Leistung:
+14.61%
1-Tages-Spanne:
$279.02
$290.65
1-Wochen-Bereich:
$262.11
$290.65
52-Wochen-Spanne:
$241.81
$293.72
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, NTRA, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
283.36 | 23.12B | 14.14B | 942.70M | 1.38B | 11.29 |
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp Holdings (LH) Q1 2026 Earnings Call Transcript - Fortune
Labcorp Holdings Inc (LH) Stock Up 3.7% but GF Value Says Overva - GuruFocus
Labcorp To Pay $14.5M To Settle Medicare Fraud Allegations Over Unnecessary Drug Testing - Yahoo Finance
Diagnostics Co. Labcorp Settles FCA Claims For $14.5M - Law360
Labcorp seen as a steady growth buy with cost c... - Pluang
Laboratory Corporation of America (LH) Settles for $14.5M Over F - GuruFocus
Labcorp Holdings: The Story Has Not Changed Materially - Seeking Alpha
Labcorp to Pay $14.5 Million to Settle False Claims Act Allegations - marketscreener.com
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cell-Based Assay Services for Preclinical Use Only Global Market Report 2026 Released — Profiles Charles River, Labcorp, Eurofins and Evotec - Yahoo Finance
Baird Adjusts Labcorp Price Target to $338 From $335, Maintains Outperform Rating - marketscreener.com
Labcorp declares quarterly dividend of $0.72 per share By Investing.com - Investing.com Nigeria
Labcorp stock holds steady as diagnostics demand stays central - Ad Hoc News
What are Wall Street analysts' target price for Labcorp Holdings stock? - MSN
Labcorp stock steadies on its diagnostics and drug development mix - Ad-hoc-news.de
Labcorp Holdings Inc. (LH) Declares Cash Dividend of $0.72 Per S - GuruFocus
Labcorp Declares $0.72 Quarterly Dividend Payable September 2026 - Minichart
Labcorp Declares $0.72 Quarterly Dividend Payable Sept. 11 - TradingView
Labcorp (NYSE: LH) sets $0.72 per-share dividend payable September 11, 2026 - Stock Titan
Labcorp stock holds steady as investors await its next catalyst - Ad-hoc-news.de
Labcorp Declares Quarterly Dividend - AOL.com
Labcorp declares quarterly dividend of $0.72 per share - Investing.com
Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable Sept. 11 to Holders of Record Aug. 28 - marketscreener.com
Labcorp Holdings (LH) Declares Consistent Dividend Amid Positive Growth Outlook - GuruFocus
Here's what to expect from Labcorp Holdings’ next earnings report - MSN
Labcorp stock holds its business focus. Clinical diagnostics remain the core. - ad-hoc-news.de
Labcorp Holdings (LH) Expands Cancer And Liver Testing, Is It Fully Priced? - Sahm
Evercore ISI Adjusts Price Target on Labcorp to $315 From $300 - Moomoo
Labcorp EVP Bryan Vaughn sells $66,968 in common stock By Investing.com - Investing.com South Africa
Labcorp chief legal officer Kyle sells $26,329 in common stock. - Investing.com UK
Labcorp EVP Bryan Vaughn sells $66,968 in common stock - Investing.com UK
Form 4 Labcorp Holdings Inc For: 6 July By Investing.com - Investing.com Nigeria
Labcorp chief legal officer Kyle sells $26,329 in common stock. By Investing.com - Investing.com Australia
Labcorp (NYSE: LH) legal chief sells shares, exercises 256 stock units - Stock Titan
Labcorp (LH) EVP sells shares after RSU vesting under Rule 10b5-1 plan - Stock Titan
Enterprise value to revenue forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Labcorp Holdings Inc. (LH) Stock Analysis: Evaluating an 8.06% Potential Upside Amid Strong Buy Ratings - DirectorsTalk Interviews
Labcorp launches FDA-cleared blood test for Alzheimer's disease - MSN
Why Labcorp Holdings (LH) Is Up 7.7% After Expanding Advanced At-Home and Blood-Based Diagnostics - Sahm
Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Kathryn W. Kyle sells 762 shares; 92 restricted shares vest (LH) - Stock Titan
Form 144 LABCORP HOLDINGS INC. For: 2 July By Investing.com - Investing.com Canada
[144] LABCORP HOLDINGS INC. SEC Filing - Stock Titan
Here's What to Expect From Labcorp Holdings’ Next Earnings Report - Barchart.com
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Form 144 LABCORP HOLDINGS INC. For: 1 July By Investing.com - Investing.com South Africa
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Labcorp Holdings Inc-Aktie (LH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Vaughn Bryan T | EVP and President, Diagnostics |
Jul 02 '26 |
Sale |
286.19 |
234 |
66,968 |
6,746 |
0.61%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):